Brachytherapy Market: Advancements in Cancer Treatment Technology Drive Growth 2031

The global brachytherapy market garnered $0.83 billion in 2021, and is estimated to generate $1.6 billion by 2031, manifesting a CAGR of 7.1% from 2022 to 2031. Brachytherapy is a type of cancer treatment that involves placing small radioactive sources directly into or near a tumor. The word "brachy" comes from Greek and means "short," referring to the short distance the radiation travels in this type of treatment.

Download Free Sample Report- https://www.alliedmarketresearch.com/request-sample/11487

During brachytherapy, the radioactive sources are usually inserted into the body using small tubes or needles, which are placed either inside the tumor or in the surrounding tissue. The radiation emitted by the sources kills cancer cells by damaging their DNA, while minimizing exposure to healthy tissues.

The sources may be left in place permanently or removed after a specific period of time, depending on the type and stage of cancer being treated. Brachytherapy can be used to treat various types of cancers, such as prostate, breast, cervical, and skin cancer, among others.

Overall, brachytherapy is a highly effective and targeted form of radiation therapy that can be an excellent option for certain types of cancer. It's important to discuss the risks and benefits of this treatment with your doctor to determine if it's the right choice for you.

Impact of Covid-19 on Brachytherapy Market:

The outbreak of the COVID-19 pandemic had a negative impact on the growth of the global brachytherapy market, owing to implementation of global lockdown which resulted to disruptions in the workflows of the healthcare industry.

Major market players witnessed a decline in sales of brachytherapy devices, which proves that the market was significantly affected by COVID-19.

A huge number of medical colleges and hospitals across the globe were reconstructed to increase the hospital capacity for patients diagnosed with COVID-19.

The COVID-19 and the associated restrictions and lockdowns affected the overall sales of brachytherapy products, owing to disruption in supply chain and cancellation of appointments.

Brachytherapy can be used to treat a variety of cancers in different parts of the body. The segments or areas that can be treated with brachytherapy include:

Prostate: Brachytherapy is commonly used to treat prostate cancer by implanting radioactive seeds directly into the prostate gland.

Gynecological: Cervical, vaginal, and endometrial cancers can be treated with brachytherapy by placing radioactive sources into the affected area.

Breast: Brachytherapy can be used as a boost treatment for breast cancer, delivering radiation directly to the tumor bed after surgery.

Head and Neck: Brachytherapy can be used to treat some types of head and neck cancers, including tongue, mouth, and throat cancers.

Skin: Brachytherapy can be used to treat skin cancers by applying a radioactive source directly to the affected area.

Eye: Brachytherapy can be used to treat certain types of eye tumors by implanting a small radioactive device inside the eye.

Esophageal: Brachytherapy can be used to treat esophageal cancer by placing a radioactive source inside a thin tube that is inserted into the esophagus.

Overall, brachytherapy can be a highly effective treatment option for a variety of cancer types, delivering targeted radiation directly to the affected area while minimizing exposure to healthy tissues.

For Purchase Inquiry- https://www.alliedmarketresearch.com/purchase-enquiry/11487

The growth of the brachytherapy market is attributed to an increase in patients suffering from prostate cancer, breast cancer, and gynecological cancer. Furthermore, increase in healthcare expenditure is expected to further drive the market growth during the forecast period.

Regional Analysis:

Asia-Pacific is expected to witness the highest CAGR during the forecast period, owing to increase in populations, surge in healthcare expenditure, increase in awareness related to use of brachytherapy to treatment of cancer.

North America (U.S., Canada, Mexico)

Europe (Germany, France, UK, Italy, Spain, Rest of Europe)

Asia-Pacific (China, Japan, India, Australia, South Korea, Rest of Asia-Pacific)

LAMEA (Brazil, Saudi Arabia, South Africa, Rest of LAMEA)

Key Market Players:

Argon Medical Devices, Inc., Eckert & Ziegler BEBIG, Elekta AB, iCAD, Inc., Siemens AG, isoray medical, inc., Merit Medical Systems, Inc., Theragenics Corporation, IsoAid, Carl Zeiss AG

Similar Research Reports for Information, Communication and Technology:

Nuclear Medicine Equipment Market:
https://www.alliedmarketresearch.com/nuclear-medicine-equipment-market

Sterilization Technologies Market: https://www.alliedmarketresearch.com/sterilization-technologies-market

Ophthalmic Devices Market:
https://www.alliedmarketresearch.com/ophthalmic-devices-market

Contact:
David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022, +1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com

About Us

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

This release was published on openPR.